S. I. Zheleznev
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
S. I. Zheleznev has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Ravil M. Sharifulin
Meshalkin National Medical Research Center
12 shared publications - Alexander Vladimirovich Bogachev-Prokophiev
Meshalkin National Medical Research Center
8 shared publications - A. S. Zalesov
Meshalkin National Medical Research Center
6 shared publications - Alexander V. Afanasyev
Meshalkin National Medical Research Center Novosibirsk Russian Federation
6 shared publications - Alexei N. Pivkin
Meshalkin National Medical Research Center
3 shared publications - Andrey V. Sapegin
Meshalkin National Medical Research Center
3 shared publications
Latest Publications
- 18 February 2026
- Published by Media Sphere Publishing Group in Russian Journal of Cardiology and Cardiovascular Surgery
- Vol. 19 (1)
Modern aspects in surgical treatment of atrial fibrillation with simultaneous mitral valve surgery via minimally invasive approach: evolution of techniques and analysis of clinical outcomes
Objective. To analyze the efficacy and specific features of surgical treatment of atrial fibrillation (AF) in mitral valve surgery via minimally invasive approach, as well as to compare the outcomes with those after conventional sternotomy. Material and methods. A systematic literature searching was conducted in the following electronic databases from their inception until June 2025: Ovid MEDLINE, EMBASE, and SCOPUS. The review examines modern atrial ablation techniques, including cryo- and radiofrequency ablation, as well as left atrial appendage exclusion methods. Comparative studies evaluating the effectiveness of minimally invasive versus standard approaches were analyzed. The authors focused on freedom from AF, complication rates and postoperative mortality. Results. Minimally invasive techniques demonstrate efficacy comparable to traditional approaches in AF treatment with freedom from atrial arrhythmias ranging from 78% to 99% within a year. Advantages of minimally invasive approach include shorter recovery time, lower complication rates (6% vs. 13%), and reduced need for pacemaker implantation (4% vs. 18%), as reported by various authors. Technological advancements in thermal ablation devices have improved precision and safety of procedures. Conclusion. Minimally invasive approach is a safe and effective alternative to conventional sternotomy for surgical treatment of AF combined with mitral valve repair. Further research should focus on optimizing techniques, refining patient selection criteria, and evaluating long-term outcomes.
- 18 February 2026
- Published by Media Sphere Publishing Group in Russian Journal of Cardiology and Cardiovascular Surgery
- Vol. 19 (1)
Modern aspects in surgical treatment of atrial fibrillation with simultaneous mitral valve surgery via minimally invasive approach: evolution of techniques and analysis of clinical outcomes
Objective. To analyze the efficacy and specific features of surgical treatment of atrial fibrillation (AF) in mitral valve surgery via minimally invasive approach, as well as to compare the outcomes with those after conventional sternotomy. Material and methods. A systematic literature searching was conducted in the following electronic databases from their inception until June 2025: Ovid MEDLINE, EMBASE, and SCOPUS. The review examines modern atrial ablation techniques, including cryo- and radiofrequency ablation, as well as left atrial appendage exclusion methods. Comparative studies evaluating the effectiveness of minimally invasive versus standard approaches were analyzed. The authors focused on freedom from AF, complication rates and postoperative mortality. Results. Minimally invasive techniques demonstrate efficacy comparable to traditional approaches in AF treatment with freedom from atrial arrhythmias ranging from 78% to 99% within a year. Advantages of minimally invasive approach include shorter recovery time, lower complication rates (6% vs. 13%), and reduced need for pacemaker implantation (4% vs. 18%), as reported by various authors. Technological advancements in thermal ablation devices have improved precision and safety of procedures. Conclusion. Minimally invasive approach is a safe and effective alternative to conventional sternotomy for surgical treatment of AF combined with mitral valve repair. Further research should focus on optimizing techniques, refining patient selection criteria, and evaluating long-term outcomes.
- Open Access
- 21 January 2026
- Published by Meshalkin National Medical Research Center in Patologiya krovoobrashcheniya i kardiokhirurgiya
- Vol. 29 (4) , 78-88
Subclinical right ventricular systolic dysfunction and left ventricular myocardial performance in patients with severe aortic stenosis: а prospective single-center non-randomized study
Background: The number of patients with aortic stenosis (AS) is increasing with the aging population. According to current guidelines, surgical treatment is recommended for severe AS in patients with symptoms of heart failure, a reduced ejection fraction (EF), and global left ventricular (LV) Strain. LVEF does not always reflect its contractility. Assessing right ventricular (RV) function is also important, as its dysfunction may persist even after aortic valve surgery. Objective: The study was aimed to assess RV global strain, strain of RV free wall and LV myocardial performance in patients with severe AS. Methods: This prospective non-randomized study included 72 patients with degenerative aortic valve disease and an effective orifice area of less than 1.0 cm2. The complex of examination methods included echocardiography and Speckle Tracking Imaging-2D Strain technology for assessing LV and RV deformation, LV myocardial function, 3D visualization of RV with subsequent construction of a 3D RV model and calculation of EF, fractional area change, linear dimensions, and tricuspid annulus displacement amplitude. Results: Decreased LV myocardial function was detected in 24 patients (33.3 %). Subclinical RV systolic dysfunction, namely decreased RV global strain, was detected in 40 (55.6 %) patients, while decreased RV free wall strain was observed in 11 (15.3 %) patients. Interplay was revealed between subclinical RV systolic dysfunction and LV myocardial performance in patients with severe AS. Conclusion: Subclinical LV and RV dysfunctions are observed in a significant number of patients with severe AS. Analysis and use of these data will enable to change the approach to the AS classification and the timing of surgical treatment in the future. Conclusion: Subclinical left and right ventricular dysfunction is observed in a significant number of patients with severe aortic stenosis based on echocardiography. Analysis and use of these data will likely lead to changes in the classification of AS and the timing of surgical treatment. Keywords: aortic stenosis, echocardiography, right ventricular systolic dysfunction, left ventricular myocardial function, right ventricular deformation.
- 21 January 2026
- Published by Meshalkin National Medical Research Center in Patologiya krovoobrashcheniya i kardiokhirurgiya
- Vol. 29 (4) , 78-88
Open AccessSubclinical right ventricular systolic dysfunction and left ventricular myocardial performance in patients with severe aortic stenosis: а prospective single-center non-randomized study
Background: The number of patients with aortic stenosis (AS) is increasing with the aging population. According to current guidelines, surgical treatment is recommended for severe AS in patients with symptoms of heart failure, a reduced ejection fraction (EF), and global left ventricular (LV) Strain. LVEF does not always reflect its contractility. Assessing right ventricular (RV) function is also important, as its dysfunction may persist even after aortic valve surgery. Objective: The study was aimed to assess RV global strain, strain of RV free wall and LV myocardial performance in patients with severe AS. Methods: This prospective non-randomized study included 72 patients with degenerative aortic valve disease and an effective orifice area of less than 1.0 cm2. The complex of examination methods included echocardiography and Speckle Tracking Imaging-2D Strain technology for assessing LV and RV deformation, LV myocardial function, 3D visualization of RV with subsequent construction of a 3D RV model and calculation of EF, fractional area change, linear dimensions, and tricuspid annulus displacement amplitude. Results: Decreased LV myocardial function was detected in 24 patients (33.3 %). Subclinical RV systolic dysfunction, namely decreased RV global strain, was detected in 40 (55.6 %) patients, while decreased RV free wall strain was observed in 11 (15.3 %) patients. Interplay was revealed between subclinical RV systolic dysfunction and LV myocardial performance in patients with severe AS. Conclusion: Subclinical LV and RV dysfunctions are observed in a significant number of patients with severe AS. Analysis and use of these data will enable to change the approach to the AS classification and the timing of surgical treatment in the future. Conclusion: Subclinical left and right ventricular dysfunction is observed in a significant number of patients with severe aortic stenosis based on echocardiography. Analysis and use of these data will likely lead to changes in the classification of AS and the timing of surgical treatment. Keywords: aortic stenosis, echocardiography, right ventricular systolic dysfunction, left ventricular myocardial function, right ventricular deformation.
- Open Access
- 6 December 2024
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 29 (12) , 6188
Transcatheter and surgical aortic valve replacement in patients at low surgical risk. Review of major studies
In recent decades, transcatheter aortic valve replacement (TAVR) has become a revolutionary method for the treatment of severe aortic stenosis, especially for patients at high surgical risk. Studies such as PARTNER and SURTAVI have confirmed the non-inferiority or superiority of TAVR compared with surgical aortic valve replacement in various risk categories. Newer technologies, including third-generation valve systems, have improved durability and reduced complications such as paravalvular regurgitation. However, long-term survival data remain limited, especially for younger patients and groups with anatomical peculiarities. International association guidelines have long favored TAVR for older patients, while surgery remains the preferred option for younger patients with low surgical risk. However, the latter point is increasingly being questioned. The article analyzes key studies, discusses current limitations, and highlights the need for long-term data to inform clinical practice. In conclusion, TAVR is a remarkable achievement in interventional cardiology, but its optimal use requires consideration of individual patient factors.
- 6 December 2024
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 29 (12) , 6188
Open AccessTranscatheter and surgical aortic valve replacement in patients at low surgical risk. Review of major studies
In recent decades, transcatheter aortic valve replacement (TAVR) has become a revolutionary method for the treatment of severe aortic stenosis, especially for patients at high surgical risk. Studies such as PARTNER and SURTAVI have confirmed the non-inferiority or superiority of TAVR compared with surgical aortic valve replacement in various risk categories. Newer technologies, including third-generation valve systems, have improved durability and reduced complications such as paravalvular regurgitation. However, long-term survival data remain limited, especially for younger patients and groups with anatomical peculiarities. International association guidelines have long favored TAVR for older patients, while surgery remains the preferred option for younger patients with low surgical risk. However, the latter point is increasingly being questioned. The article analyzes key studies, discusses current limitations, and highlights the need for long-term data to inform clinical practice. In conclusion, TAVR is a remarkable achievement in interventional cardiology, but its optimal use requires consideration of individual patient factors.
- Open Access
- 11 October 2023
- Published by Intermedservice Ltd in Eurasian heart journal
- No. 3,p. 54-61
«Edge-to-edge» mitral valve repair for septal myectomy versus isolated myectomy: a pilot randomized trial
Background. Septal myectomy is currently the «gold» standard of surgical treatment of patients with obstructive hypertrophic cardiomyopathy. In some cases, isolated septal myectomy does not eliminate SAM-induced mitral insufficiency. Cardiac surgeons sometimes perform combined interventions on the mitral valve, such as «edge-to-edge» mitral valve repair.Aim. Evaluation of the safety and efficacy of combined edge-to-edge mitral valve repair in septal myectomy compared with isolated septal myectomy.Methods. Recruitment to the study was carried out for the period from 2019 to 2022 at the Meshalkin National Medical Research Center of the Ministry of Health of Russia. Twenty patients was performed combined «edge-to-edge» mitral valve repair with septal myectomy, 20 patients with isolated myectomy were included in the control group. The study assessed immediate and mid-term results after 12 months.Results. Combined edge-to-edge mitral valve repair demonstrates better intraoperative efficacy compared with isolated septal myectomy (95,0% versus 50,0%, p=0,001), but is accompanied by increased transmitral peak (6,8±2,1 vs 4,9±3,2 mmHg, p=0,03) and medium (3,4±1,4 vs 2,5±1,7 mmHg, p=0,05) gradients. Both techniques are associated with a low level of hospital mortality and complications in the early postoperative period, high survival after 12 months.Conclusion. Combined mitral valve repair using the «edge-to-edge» technique is comparable safe to isolated myectomy, but better eliminates SAM-induced mitral insufficiency. «Edge-to-edge» mitral valve repair is characterized by increased transmitral gradients.
- 11 October 2023
- Published by Intermedservice Ltd in Eurasian heart journal
- No. 3,p. 54-61
Open Access«Edge-to-edge» mitral valve repair for septal myectomy versus isolated myectomy: a pilot randomized trial
Background. Septal myectomy is currently the «gold» standard of surgical treatment of patients with obstructive hypertrophic cardiomyopathy. In some cases, isolated septal myectomy does not eliminate SAM-induced mitral insufficiency. Cardiac surgeons sometimes perform combined interventions on the mitral valve, such as «edge-to-edge» mitral valve repair.Aim. Evaluation of the safety and efficacy of combined edge-to-edge mitral valve repair in septal myectomy compared with isolated septal myectomy.Methods. Recruitment to the study was carried out for the period from 2019 to 2022 at the Meshalkin National Medical Research Center of the Ministry of Health of Russia. Twenty patients was performed combined «edge-to-edge» mitral valve repair with septal myectomy, 20 patients with isolated myectomy were included in the control group. The study assessed immediate and mid-term results after 12 months.Results. Combined edge-to-edge mitral valve repair demonstrates better intraoperative efficacy compared with isolated septal myectomy (95,0% versus 50,0%, p=0,001), but is accompanied by increased transmitral peak (6,8±2,1 vs 4,9±3,2 mmHg, p=0,03) and medium (3,4±1,4 vs 2,5±1,7 mmHg, p=0,05) gradients. Both techniques are associated with a low level of hospital mortality and complications in the early postoperative period, high survival after 12 months.Conclusion. Combined mitral valve repair using the «edge-to-edge» technique is comparable safe to isolated myectomy, but better eliminates SAM-induced mitral insufficiency. «Edge-to-edge» mitral valve repair is characterized by increased transmitral gradients.
- 23 April 2023
- Published by Media Sphere Publishing Group in Russian Journal of Cardiology and Cardiovascular Surgery
- Vol. 16 (3)
Bentall-DeBono procedure with semistented tissue aortic valve prosthesis
Currently, the Bentall-DeBono procedure is the gold standard in the treatment of aortic valve defects in patients with aortic root aneurysm. Advanced age patients in cardiac surgery increase the need for implantation of biological prostheses. Technical difficulties of development of valved conduits with biological prostheses force surgeons to design valved conduits in hand-made fashion. We performed Bentall-DeBono procedure with semistented tissue aortic valve prosthesis. Technical aspects of surgery, perioperative and immediate postoperative results are described.
- 23 April 2023
- Published by Media Sphere Publishing Group in Russian Journal of Cardiology and Cardiovascular Surgery
- Vol. 16 (3)
Bentall-DeBono procedure with semistented tissue aortic valve prosthesis
Currently, the Bentall-DeBono procedure is the gold standard in the treatment of aortic valve defects in patients with aortic root aneurysm. Advanced age patients in cardiac surgery increase the need for implantation of biological prostheses. Technical difficulties of development of valved conduits with biological prostheses force surgeons to design valved conduits in hand-made fashion. We performed Bentall-DeBono procedure with semistented tissue aortic valve prosthesis. Technical aspects of surgery, perioperative and immediate postoperative results are described.
- Open Access
- 30 March 2023
- Published by Meshalkin National Medical Research Center in Patologiya krovoobrashcheniya i kardiokhirurgiya
- Vol. 27 (1) , 7-16
Aortic allografts for surgical treatment of prosthetic valve endocarditis
Background: Prosthetic valve endocarditis, the most severe form of infective endocarditis, occurs in 1-6% of patients with valve prostheses and is still associated with poor prognosis and high in-hospital mortality.Objective: To assess outcomes of allograft aortic root replacement in patients with prosthetic valve endocarditis.Methods: The retrospective analysis included adult patients with prosthetic valve endocarditis, who underwent allograft aortic root replacement between 2011 and 2022.Results: Of 15 study patients, early infective endocarditis was found in 60.0% of the cases. The most common cause was Staphylococcus aureus (26.7%). Early mortality was 13.3%. Thromboembolic events occurred in 2 patients (13.3%). The median follow-up period was 48.5 (6-140) months. Late death was reported in 1 patient. The 5-year survival rate was 79.0%. One patient had recurrent infective endocarditis. Two patients underwent reintervention: one for a proximal anastomotic pseudoaneurysm and another one for structural degeneration of the allograft. Five-year freedom from reintervention was 91.7%.Conclusion: Due to the high rate of the freedom from recurrent infective endocarditis, allograft aortic root replacement is an effective treatment for patients with prosthetic valve endocarditis. Received 7 November 2022. Revised 9 December 2022. Accepted 20 December 2022. Funding: The study was supported by the grant of the president of the Russian Federation (No. 075-15-2022-823). Conflict of interest: The authors declare no conflict of interest. Contribution of the authorsConception and study design: A.V. Bogachev-ProkophievData collection and analysis: A.V. Karadzha, A.N. Pivkin, A.S. ZalesovStatistical analysis: R.M. Sharifulin, A.V. AfanasyevDrafting the article: R.M. Sharifulin, A.V. AfanasyevCritical revision of the article: A.V. Bogachev-Prokophiev, S.I. ZheleznevFinal approval of the version to be published: A.V. Bogachev-Prokophiev, R.M. Sharifulin, S.I. Zheleznev, A.V. Karadzha, A.V. Afanasyev, A.N. Pivkin, A.S. Zalesov
- 30 March 2023
- Published by Meshalkin National Medical Research Center in Patologiya krovoobrashcheniya i kardiokhirurgiya
- Vol. 27 (1) , 7-16
Open AccessAortic allografts for surgical treatment of prosthetic valve endocarditis
Background: Prosthetic valve endocarditis, the most severe form of infective endocarditis, occurs in 1-6% of patients with valve prostheses and is still associated with poor prognosis and high in-hospital mortality.Objective: To assess outcomes of allograft aortic root replacement in patients with prosthetic valve endocarditis.Methods: The retrospective analysis included adult patients with prosthetic valve endocarditis, who underwent allograft aortic root replacement between 2011 and 2022.Results: Of 15 study patients, early infective endocarditis was found in 60.0% of the cases. The most common cause was Staphylococcus aureus (26.7%). Early mortality was 13.3%. Thromboembolic events occurred in 2 patients (13.3%). The median follow-up period was 48.5 (6-140) months. Late death was reported in 1 patient. The 5-year survival rate was 79.0%. One patient had recurrent infective endocarditis. Two patients underwent reintervention: one for a proximal anastomotic pseudoaneurysm and another one for structural degeneration of the allograft. Five-year freedom from reintervention was 91.7%.Conclusion: Due to the high rate of the freedom from recurrent infective endocarditis, allograft aortic root replacement is an effective treatment for patients with prosthetic valve endocarditis. Received 7 November 2022. Revised 9 December 2022. Accepted 20 December 2022. Funding: The study was supported by the grant of the president of the Russian Federation (No. 075-15-2022-823). Conflict of interest: The authors declare no conflict of interest. Contribution of the authorsConception and study design: A.V. Bogachev-ProkophievData collection and analysis: A.V. Karadzha, A.N. Pivkin, A.S. ZalesovStatistical analysis: R.M. Sharifulin, A.V. AfanasyevDrafting the article: R.M. Sharifulin, A.V. AfanasyevCritical revision of the article: A.V. Bogachev-Prokophiev, S.I. ZheleznevFinal approval of the version to be published: A.V. Bogachev-Prokophiev, R.M. Sharifulin, S.I. Zheleznev, A.V. Karadzha, A.V. Afanasyev, A.N. Pivkin, A.S. Zalesov
- Open Access
- 28 September 2021
- Published by Meshalkin National Medical Research Center in Patologiya krovoobrashcheniya i kardiokhirurgiya
- Vol. 25 (3) , 51-60
Short-term outcomes of surgical atrial ablation and septal myectomy
Background. Hypertrophic cardiomyopathy is one of the most common types of cardiomyopathy. The appearance of atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy is associated with significant clinical worsening. Outcomes of surgical ablation and septal myectomy in these patients are limited.Aim. This retrospective study aimed to evaluate short-term outcomes of concomitant surgical ablation and septal myectomy in patients with obstructive hypertrophic cardiomyopathy and atrial fibrillation.Methods. Fifty-five patients with hypertrophic obstructive cardiomyopathy and atrial fibrillation who underwent concomitant surgical ablation and septal myectomy between 2014 and 2019 were analysed. Patients with paroxysmal atrial fibrillation predominantly underwent left atrial ablation, and those with nonparoxysmal atrial fibrillation predominantly underwent the Maze IV procedure. Surgical ablation was performed using cryoablation alone (83.6%) or in combination with radiofrequency energy (16.4%).Results. Hospital mortality was 1.8%. Incidence of major adverse events was 3.6%. Sinus node dysfunction and atrioventricular block occurred in 7.3% and 1.8% of patients, respectively. Bleeding requiring revision occurred in 2 (3.6%) patients. Forty-nine (89.1%) patients had stable sinus rhythm and five (9.1%) were on dual-chamber pacemaker stimulation at the time of discharge.Conclusion. Concomitant septal myectomy and surgical ablation are feasible and safe in patients with hypertrophic obstructive cardiomyopathy and atrial fibrillation.Received 5 April 2021. Revised 16 May 2021. Accepted 17 May 2021.Funding: The study did not have sponsorship.Conflict of interest: The authors declare no conflicts of interests.Contribution of the authorsConception and study design: A.S. Zalesov, A.V. Bogachev-ProkophievData collection and analysis: A.S. Zalesov, S.A. Budagaev, A.V. SapeginStatistical analysis: A.S. Zalesov, A.V. Afanasyev, R.M. SharifulinDrafting the article: A.S. ZalesovCritical revision of the article: A.V. Bogachev-Prokophiev, S.I. Zheleznev, I.I. DeminFinal approval of the version to be published: A.S. Zalesov, A.V. Bogachev-Prokophiev, A.V. Afanasyev, R.M. Sharifulin, A.V. Sapegin, S.A. Budagaev, S.I. Zheleznev, I.I. Demin
- 28 September 2021
- Published by Meshalkin National Medical Research Center in Patologiya krovoobrashcheniya i kardiokhirurgiya
- Vol. 25 (3) , 51-60
Open AccessShort-term outcomes of surgical atrial ablation and septal myectomy
Background. Hypertrophic cardiomyopathy is one of the most common types of cardiomyopathy. The appearance of atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy is associated with significant clinical worsening. Outcomes of surgical ablation and septal myectomy in these patients are limited.Aim. This retrospective study aimed to evaluate short-term outcomes of concomitant surgical ablation and septal myectomy in patients with obstructive hypertrophic cardiomyopathy and atrial fibrillation.Methods. Fifty-five patients with hypertrophic obstructive cardiomyopathy and atrial fibrillation who underwent concomitant surgical ablation and septal myectomy between 2014 and 2019 were analysed. Patients with paroxysmal atrial fibrillation predominantly underwent left atrial ablation, and those with nonparoxysmal atrial fibrillation predominantly underwent the Maze IV procedure. Surgical ablation was performed using cryoablation alone (83.6%) or in combination with radiofrequency energy (16.4%).Results. Hospital mortality was 1.8%. Incidence of major adverse events was 3.6%. Sinus node dysfunction and atrioventricular block occurred in 7.3% and 1.8% of patients, respectively. Bleeding requiring revision occurred in 2 (3.6%) patients. Forty-nine (89.1%) patients had stable sinus rhythm and five (9.1%) were on dual-chamber pacemaker stimulation at the time of discharge.Conclusion. Concomitant septal myectomy and surgical ablation are feasible and safe in patients with hypertrophic obstructive cardiomyopathy and atrial fibrillation.Received 5 April 2021. Revised 16 May 2021. Accepted 17 May 2021.Funding: The study did not have sponsorship.Conflict of interest: The authors declare no conflicts of interests.Contribution of the authorsConception and study design: A.S. Zalesov, A.V. Bogachev-ProkophievData collection and analysis: A.S. Zalesov, S.A. Budagaev, A.V. SapeginStatistical analysis: A.S. Zalesov, A.V. Afanasyev, R.M. SharifulinDrafting the article: A.S. ZalesovCritical revision of the article: A.V. Bogachev-Prokophiev, S.I. Zheleznev, I.I. DeminFinal approval of the version to be published: A.S. Zalesov, A.V. Bogachev-Prokophiev, A.V. Afanasyev, R.M. Sharifulin, A.V. Sapegin, S.A. Budagaev, S.I. Zheleznev, I.I. Demin
- Open Access
- 14 September 2020
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 25 (8) , 3847
First experience of transcatheter implantation of a Russian-made MedLab-CT prosthesis in a patient with dysfunction of biological mitral valve prosthesis
We present a case report of successful transcatheter implantation of a Russian-made cardiac valve prosthesis in a patient with dysfunction of biological mitral valve prosthesis (valve-in-valve). A patient aged 78 years with a high surgical risk and severe heart failure due to mitral valve bioprosthesis dysfunction is described. Fluoroscopyand transesophageal echocardiography-guided transapical implantation of a MedLab-CT prosthesis (23 mm) was made. When a heart rate of 180 beats per minute, a stent prosthesis was implanted. Transcatheter implant valve functioned properly after surgery. The patient was discharged in satisfactory condition.
- 14 September 2020
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 25 (8) , 3847
Open AccessFirst experience of transcatheter implantation of a Russian-made MedLab-CT prosthesis in a patient with dysfunction of biological mitral valve prosthesis
We present a case report of successful transcatheter implantation of a Russian-made cardiac valve prosthesis in a patient with dysfunction of biological mitral valve prosthesis (valve-in-valve). A patient aged 78 years with a high surgical risk and severe heart failure due to mitral valve bioprosthesis dysfunction is described. Fluoroscopyand transesophageal echocardiography-guided transapical implantation of a MedLab-CT prosthesis (23 mm) was made. When a heart rate of 180 beats per minute, a stent prosthesis was implanted. Transcatheter implant valve functioned properly after surgery. The patient was discharged in satisfactory condition.
- Open Access
- 6 December 2018
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- No. 11,p. 137-144
The results of transcatheter mitral valve replacement
Mitral insufficiency is one of the most common valvular pathology. In almost half of the patients, standard mitral valve replacement using extracorporeal circulation cannot be used due to the high risk of complications. In recent years, for this category of patients a method for transcatheter mitral valve replacement has been proposed. Now it is known about a few transcatheter prostheses for implantation into the native mitral valve that are at the stage of preclinical or clinical trials. This article analyzes the results of the clinical use of prostheses for transcatheter mitral valve replacement.
- 6 December 2018
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- No. 11,p. 137-144
Open AccessThe results of transcatheter mitral valve replacement
Mitral insufficiency is one of the most common valvular pathology. In almost half of the patients, standard mitral valve replacement using extracorporeal circulation cannot be used due to the high risk of complications. In recent years, for this category of patients a method for transcatheter mitral valve replacement has been proposed. Now it is known about a few transcatheter prostheses for implantation into the native mitral valve that are at the stage of preclinical or clinical trials. This article analyzes the results of the clinical use of prostheses for transcatheter mitral valve replacement.
- Open Access
- 1 January 2018
- Published by Media Sphere Publishing Group in Russian Journal of Cardiology and Cardiovascular Surgery
- Vol. 11 (5) , 6-14
Comparative efficacy of biatrial and left atrial surgical ablation for atrial fibrillation
- 1 January 2018
- Published by Media Sphere Publishing Group in Russian Journal of Cardiology and Cardiovascular Surgery
- Vol. 11 (5) , 6-14
Open AccessComparative efficacy of biatrial and left atrial surgical ablation for atrial fibrillation